Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Salmeterol on Walking Capacity in Patients With COPD

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Laval University
ClinicalTrials.gov Identifier:
NCT00525564
First received: September 4, 2007
Last updated: September 5, 2007
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given